Little Excitement Around Silence Therapeutics Plc's (NASDAQ:SLN) Revenues As Shares Take 29% Pounding

Simply Wall StMar 22 08:15 ET

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT NewswiresMar 7 11:14 ET

Silence Therapeutics: Strategic Focus and Strong Financials Poised for Growth With Promising RNAi Pipeline

TipRanksMar 7 06:28 ET

Revenue Downgrade: Here's What Analysts Forecast For Silence Therapeutics Plc (NASDAQ:SLN)

Yahoo FinanceMar 6 05:41 ET

Express News | Morgan Stanley Maintains Overweight on Silence Therapeutics, Lowers Price Target to $45

BenzingaMar 5 09:08 ET

Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

BusinesswireMar 5 08:00 ET